AU4227685A - 2 - amino - pyrimidines - Google Patents

2 - amino - pyrimidines

Info

Publication number
AU4227685A
AU4227685A AU42276/85A AU4227685A AU4227685A AU 4227685 A AU4227685 A AU 4227685A AU 42276/85 A AU42276/85 A AU 42276/85A AU 4227685 A AU4227685 A AU 4227685A AU 4227685 A AU4227685 A AU 4227685A
Authority
AU
Australia
Prior art keywords
pyrimidines
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42276/85A
Other languages
English (en)
Inventor
Masashi Hashimoto
David Hulme Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848412184A external-priority patent/GB8412184D0/en
Priority claimed from GB858500417A external-priority patent/GB8500417D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of AU4227685A publication Critical patent/AU4227685A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU42276/85A 1984-05-12 1985-05-10 2 - amino - pyrimidines Abandoned AU4227685A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB848412184A GB8412184D0 (en) 1984-05-12 1984-05-12 Biologically active nitrogen heterocycles
GB8412184 1984-05-12
GB858500417A GB8500417D0 (en) 1985-01-08 1985-01-08 Biologically active nitrogen heterocycles
GB8500417 1985-01-08

Publications (1)

Publication Number Publication Date
AU4227685A true AU4227685A (en) 1985-11-14

Family

ID=26287736

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42276/85A Abandoned AU4227685A (en) 1984-05-12 1985-05-10 2 - amino - pyrimidines

Country Status (9)

Country Link
EP (1) EP0164204A1 (en, 2012)
AU (1) AU4227685A (en, 2012)
DK (1) DK203985A (en, 2012)
ES (1) ES8609275A1 (en, 2012)
FI (1) FI851837A7 (en, 2012)
GR (1) GR851131B (en, 2012)
IL (1) IL75147A0 (en, 2012)
NO (1) NO851877L (en, 2012)
PT (1) PT80432B (en, 2012)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569194B2 (en) * 1985-07-24 1988-01-21 Pfizer Inc. 5-hydroxy-2-amino-pyrimidines
AU591223B2 (en) * 1986-01-13 1989-11-30 American Cyanamid Company 4,5,6-substituted-2-pyrimidinamines

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
US5064963A (en) * 1990-04-25 1991-11-12 American Cyanamid Company Process for the synthesis of n-(3-(1h-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines
CA2365269A1 (en) * 1991-01-31 1992-08-20 Warner-Lambert Company Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
US5177079A (en) * 1991-01-31 1993-01-05 Warner-Lambert Company 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
US5248682A (en) * 1991-01-31 1993-09-28 Warner-Lambert Company 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5276186A (en) * 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
US5521184A (en) * 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
US5543520A (en) * 1993-10-01 1996-08-06 Ciba-Geigy Corporation Pyrimidine derivatives
ATE208772T1 (de) * 1993-10-01 2001-11-15 Novartis Erfind Verwalt Gmbh Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
JPH08503971A (ja) * 1993-10-01 1996-04-30 チバ−ガイギー アクチェンゲゼルシャフト ピリミジンアミン誘導体及びその調製のための方法
JP2000506532A (ja) 1996-03-13 2000-05-30 スミスクライン・ビーチャム・コーポレイション サイトカイン介在疾患の治療にて有用な新規ピリミジン化合物
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
GB2361236B (en) 2000-03-29 2002-04-24 Cyclacel Ltd Pyrimidines useful against proliferative disorders
MXPA04004178A (es) 2001-11-01 2004-09-06 Janssen Pharmaceutica Nv Heteroarilaminas como inhibidores de glucogeno cintasa cinasa 3beta.
NZ531854A (en) * 2001-11-01 2006-03-31 Janssen Pharmaceutica Nv Aminobenzamide derivatives as glycogen synthase kinase 3beta inhibitors
AR038368A1 (es) 2002-02-01 2005-01-12 Novartis Ag Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
CA2533474A1 (en) 2003-07-30 2005-02-10 Shudong Wang 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
JP4790703B2 (ja) * 2004-04-07 2011-10-12 武田薬品工業株式会社 環式化合物
CA2576159A1 (en) 2004-08-27 2006-03-02 Cyclacel Limited Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
KR101415426B1 (ko) 2005-09-27 2014-07-04 아이알엠 엘엘씨 디아릴아민-함유 화합물 및 조성물, 및 c-kit 수용체의조절제로서의 그의 용도
GB0606774D0 (en) * 2006-04-03 2006-05-10 Novartis Ag Organic compounds
JP5160636B2 (ja) 2007-05-04 2013-03-13 アイアールエム・リミテッド・ライアビリティ・カンパニー c−kitおよびPDGFRキナーゼ阻害剤としてのピリミジン誘導体および組成物
AU2008289037B2 (en) * 2007-08-22 2012-03-01 Novartis Ag 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
ES2368876T3 (es) 2007-08-22 2011-11-23 Irm Llc Derivados de 2-heteroarilaminopirimidina como inhibidores de cinasa.
WO2009143183A1 (en) * 2008-05-19 2009-11-26 University Of Tennessee Research Foundation, The Pyrimidine non-classical cannabinoid compounds and related methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496179A (en) * 1967-10-11 1970-02-17 Pfizer & Co C 2-amino-3,4-dihydroquinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
CA961855A (en) * 1969-10-16 1975-01-28 Eli Lilly And Company Immunosuppressants and anti-viral agents
US3900476A (en) * 1973-05-17 1975-08-19 Upjohn Co 2(2'-pyrimidylamino)quinazolines and their preparation
US4010269A (en) * 1975-06-16 1977-03-01 The Upjohn Company Antiviral quinazoline compositions and methods of use
DE3220118A1 (de) * 1982-05-28 1983-12-01 Bayer Ag, 5090 Leverkusen Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569194B2 (en) * 1985-07-24 1988-01-21 Pfizer Inc. 5-hydroxy-2-amino-pyrimidines
AU591223B2 (en) * 1986-01-13 1989-11-30 American Cyanamid Company 4,5,6-substituted-2-pyrimidinamines

Also Published As

Publication number Publication date
DK203985A (da) 1985-11-13
GR851131B (en, 2012) 1985-11-25
ES8609275A1 (es) 1986-07-16
ES543047A0 (es) 1986-07-16
NO851877L (no) 1985-11-13
FI851837A0 (fi) 1985-05-09
FI851837L (fi) 1985-11-13
IL75147A0 (en) 1985-09-29
FI851837A7 (fi) 1985-11-13
DK203985D0 (da) 1985-05-08
PT80432A (en) 1985-06-01
PT80432B (en) 1987-04-16
EP0164204A1 (en) 1985-12-11

Similar Documents

Publication Publication Date Title
AU4227685A (en) 2 - amino - pyrimidines
AU4568985A (en) Tryptamine-5-methanesulfonamide
AU4401185A (en) Belastungsabhangig frequenzvariabler herzschrittmacher
AU4222285A (en) Pyrrolobenzimidazoles
AU3839785A (en) Sammelpackung
AU4254685A (en) Arylhydroxamates
AU4256585A (en) 1-heteroaryl-4-aryl-pyrazolin-5-ones
AU3749685A (en) Induktionsmotor
AU4105285A (en) Tetrahydrofuran-2-ylmethylamines
AU4061285A (en) Schaltersicherungseinheit
AU4118385A (en) Verbindungselement
AU4299085A (en) Medizinisches schwingbett
AU4459585A (en) Morpholinols
AU4542985A (en) Linear-antriebsvorrichtung
AU4541685A (en) Bandspanne
AU4422985A (en) Leucotriene-antagonistic thioethehers
AU4544085A (en) Fiberdoseringsanordning
AU4357485A (en) Injektionsspritze
AU4274285A (en) Cycloalkane-indene-carboximidamides
AU4271085A (en) Metallophosphoaluminates
AU4061585A (en) Automatisk fadolsaftapningsanlaeg
AU4216685A (en) Aminocarnitines
AU3067684A (en) Helicoplane
AU4489185A (en) Pyridazinylimidazolinones
AU4356785A (en) Reinigungsburste